Composition
- Active ingredients
- ORITAVANCIN DIPHOSPHATE EQ 400MG BASE/VIAL
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA206334.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Orbactiv
- Active substance
- oritavancin diphosphate
- Route
- Intravenous
- Dosage form
- Powder
- Applicant
- Melinta Therap
- Status
- Prescription
- FDA approval
- 6 Aug 2014
- Application
- NDA206334-001